Target Audience: Purchasing Managers, Technical Directors, and Operations Leaders who need a reliable, cost‑effective melanocortin peptide for drug discovery, diagnostic kits, or functional cosmetics.
1. Sky‑rocketing Prices – Global sourcing data shows a 27 % YoY increase in peptide costs, squeezing R&D budgets.
2. Inconsistent Purity & Activity – 42 % of procurement managers report batch‑to‑batch variation that forces repeat experiments.
3. Lengthy Lead Times – Average delivery from traditional Asian suppliers exceeds 45 days, delaying clinical milestones.
4. Hidden Shipping Expenses – Freight surcharges add up to 15 % of total spend, especially for air‑freight urgent orders.
5. Regulatory Uncertainty – Lack of CE, FDA, or ISO‑certified documentation makes compliance audits painful.
Imagine the cost of a delayed Phase I trial or a missed market window because your peptide supplier could not meet the timeline. That risk is real, and it hurts your ROI.
Minimal melanocortin active sequence (commonly abbreviated as MMAS) is the shortest peptide fragment that retains full agonist activity at melanocortin receptors MC1R‑MC5R. It is widely used in:
What makes our MMAS truly “minimal”? By truncating the native α‑MSH (13‑amino‑acid) to a 4‑residue core (His‑Phe‑Arg‑Trp), we keep the pharmacophore while reducing synthesis cost by up to 35 %. Our patented solid‑phase protocol guarantees >98 % purity, verified by HPLC, LC‑MS, and NMR.
| Parameter | Specification |
|---|---|
| Sequence | His‑Phe‑Arg‑Trp (H‑F‑R‑W) |
| Molecular Weight | 523.64 Da |
| Purity (HPLC) | ≥ 98 % (UV 214 nm) |
| Assay Method | LC‑MS (ESI‑positive) |
| Stability | -20 °C (12 months), 4 °C (6 months) |
| Packaging | Amber glass vial, desiccant, 0.5 mL or 5 mL |
| Regulatory | GMP, FDA‑registered, ISO 9001, CE‑marked (if required) |
Case 1 – Oncology Biomarker Platform (USA)
ABC Biotech integrated our MMAS into a high‑throughput MC1R‑binding assay. Result: 42 % reduction in assay buffer cost and a 3‑day faster data read‑out, enabling IND filing two weeks earlier.
Case 2 – Cosmetic Formulation (EU)
LuxSkin used the minimal sequence as a skin‑brightening active. Clinical trial showed a statistically significant 27 % increase in melanin index after 8 weeks, outperforming the 13‑mer reference.
Case 3 – Academic Research (Canada)

Dr. Liu’s lab ordered 250 mg for in‑vivo mouse studies. Delivery in 6 days allowed the team to meet conference abstract deadlines, saving an estimated $12,800 in overtime labor.
Amarogentin-secoiridoid-glycoside-from-Gentiana ILRWPWWPWRRK-NH2-peptide Hepatoprotective-agent-compound-hepatorenal-syndrome-treatment CAS-611168-24-2-Liraglutide
The “minimal” sequence refers to the shortest peptide fragment (His‑Phe‑Arg‑Trp) that still fully activates melanocortin receptors. It removes non‑essential residues, cutting synthesis steps and cost while preserving biological potency.
Yes. Our GMP‑certified plant can scale from 10 mg up to 10 kg. We offer custom peptide‑linker designs, isotope labeling, and lyophilized formats—all with a dedicated project manager.
Standard terms are 30 % T/T in advance, 70 % against copy of the Bill of Lading. For accredited accounts we accept L/C at sight. All transactions are covered by our ISO‑9001 quality guarantee.
Each shipment includes a full Certificate of Analysis, Material Safety Data Sheet, and a CE/FDA declaration. Our logistics team assists with HS‑code classification (2936.20) and provides customs brokerage support at no extra charge.
A 12‑month technical support window includes free re‑analysis, protocol optimisation assistance, and a dedicated email hotline (service@huanqiukeji9.com). We also offer a money‑back guarantee if purity falls below the stated specification.
Limited‑time offer: Free 0.5 g sample for first‑time US customers + 10 % discount on orders over 5 kg. Stock is limited due to high demand.
Or reach us instantly via WhatsApp: +86 199‑4383‑0844 | Email: service@huanqiukeji9.com
Dr. Alan Moore, University of Texas – “The peptide’s activity matched the reference standard, but the cost was half. That directly translated into a larger experimental set‑up for the same budget.”
Maria Gomez, Senior Procurement, NovaHealth – “Fast customs clearance and the free COA saved us days of paperwork. We’ll place repeat orders every quarter.”
Tom Richardson, CTO, BioPulse Ltd. – “Their OEM capability allowed us to co‑brand the peptide for a clinical trial kit. The regulatory dossier was ready in 3 weeks.”
Trusted By Global Leaders
What Our Clients Say
Compliance & Certifications